News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
840,535 Results
Type
Article (86232)
Company Profile (48)
Press Release (754250)
Multimedia
Podcasts (83)
Webinars (22)
Section
Business (231791)
Career Advice (4093)
Deals (39667)
Drug Delivery (127)
Drug Development (90788)
Employer Resources (193)
FDA (18058)
Job Trends (17321)
News (395133)
Policy (39730)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
Academia (2994)
Accelerated approval (22)
Adcomms (21)
Allergies (91)
Alliances (56516)
ALS (104)
Alzheimer's disease (1529)
Antibody-drug conjugate (ADC) (183)
Approvals (18270)
Artificial intelligence (301)
Autoimmune disease (76)
Automation (28)
Bankruptcy (400)
Best Places to Work (12282)
BIOSECURE Act (11)
Biosimilars (124)
Biotechnology (30)
Bladder cancer (85)
Brain cancer (30)
Breast cancer (354)
Cancer (2463)
Cardiovascular disease (331)
Career advice (3514)
Career pathing (22)
CAR-T (172)
CDC (20)
Celiac Disease (1)
Cell therapy (438)
Cervical cancer (22)
Clinical research (73985)
Collaboration (731)
Compensation (184)
Complete response letters (31)
COVID-19 (2854)
CRISPR (61)
C-suite (250)
Cystic fibrosis (115)
Data (3921)
Decentralized trials (1)
Denatured (31)
Depression (98)
Diabetes (349)
Diagnostics (6796)
Digital health (23)
Diversity (6)
Diversity, equity & inclusion (48)
Drug discovery (117)
Drug pricing (158)
Drug shortages (14)
Duchenne muscular dystrophy (107)
Earnings (96238)
Editorial (26)
Employer branding (24)
Employer resources (163)
Events (127538)
Executive appointments (278)
FDA (19973)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (9)
Frontotemporal dementia (17)
Funding (680)
Gene editing (119)
Generative AI (30)
Gene therapy (332)
GLP-1 (924)
Government (5158)
Grass and pollen (4)
Guidances (257)
Healthcare (20649)
HIV (47)
Huntington's disease (29)
IgA nephropathy (69)
Immunology and inflammation (129)
Immuno-oncology (22)
Indications (62)
Infectious disease (3015)
Inflammatory bowel disease (151)
Inflation Reduction Act (17)
Influenza (64)
Intellectual property (97)
Interviews (805)
IPO (17519)
IRA (60)
Job creations (5179)
Job search strategy (2848)
JPM (32)
Kidney cancer (6)
Labor market (47)
Layoffs (584)
Leadership (22)
Legal (10036)
Liver cancer (74)
Longevity (10)
Lung cancer (319)
Lymphoma (218)
Machine learning (24)
Management (61)
Manufacturing (360)
MASH (122)
Medical device (14589)
Medtech (14617)
Mergers & acquisitions (22271)
Metabolic disorders (931)
Multiple sclerosis (111)
NASH (18)
Neurodegenerative disease (184)
Neuropsychiatric disorders (52)
Neuroscience (2327)
NextGen: Class of 2026 (7418)
Non-profit (5054)
Now hiring (35)
Obesity (441)
Opinion (299)
Ovarian cancer (86)
Pain (145)
Pancreatic cancer (91)
Parkinson's disease (197)
Partnered (20)
Patents (214)
Patient recruitment (259)
Peanut (47)
People (64258)
Pharmaceutical (13)
Pharmacy benefit managers (18)
Phase 1 (22660)
Phase 2 (32070)
Phase 3 (24437)
Pipeline (3121)
Policy (180)
Postmarket research (3540)
Preclinical (10272)
Press Release (72)
Prostate cancer (144)
Psychedelics (32)
Radiopharmaceuticals (224)
Rare diseases (566)
Real estate (7386)
Recruiting (75)
Regulatory (27420)
Reports (50)
Research institute (2661)
Resumes & cover letters (646)
Rett syndrome (10)
RNA editing (8)
RSV (48)
Schizophrenia (97)
Series A (128)
Series B (80)
Service/supplier (1)
Sickle cell disease (76)
Special edition (16)
Spinal muscular atrophy (163)
Sponsored (41)
Startups (4287)
State (1)
Stomach cancer (9)
Supply chain (45)
Tariffs (38)
The Weekly (51)
Vaccines (743)
Venture capital (35)
Weight loss (323)
Women's health (46)
Worklife (14)
Date
Last 7 days (254)
Last 30 days (895)
Last 365 days (14257)
2026 (1276)
2025 (14464)
2024 (28483)
2023 (42564)
2022 (53928)
2021 (58722)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1273)
Alabama (58)
Alaska (7)
Arizona (249)
Arkansas (9)
Asia (50002)
Australia (8737)
California (5538)
Canada (1585)
China (544)
Colorado (268)
Connecticut (224)
Delaware (180)
Europe (114415)
Florida (755)
Georgia (216)
Hawaii (2)
Idaho (64)
Illinois (523)
India (31)
Indiana (349)
Iowa (3)
Japan (218)
Kansas (111)
Kentucky (17)
Louisiana (12)
Maine (64)
Maryland (746)
Massachusetts (3971)
Michigan (191)
Minnesota (398)
Mississippi (3)
Missouri (46)
Montana (24)
Nebraska (25)
Nevada (73)
New Hampshire (69)
New Jersey (1718)
New Mexico (22)
New York (1513)
North Carolina (923)
North Dakota (8)
Northern California (2966)
Ohio (201)
Oklahoma (15)
Oregon (32)
Pennsylvania (1178)
Puerto Rico (10)
Rhode Island (19)
South America (1653)
South Carolina (40)
Southern California (1979)
Tennessee (80)
Texas (818)
United States (20987)
Utah (166)
Vermont (1)
Virginia (140)
Washington D.C. (33)
Washington State (505)
West Virginia (1)
Wisconsin (53)
Wyoming (1)
840,535 Results for "red cross".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bausch Health Provides Update on RED-C Phase 3 Clinical Trials
January 26, 2026
·
3 min read
Press Releases
Overcoming the Wall: How Far Has BBB-Crossing Antibody Technology Truly Advanced? - Commentary by Unexakorea
January 26, 2026
·
4 min read
Press Releases
Onco-Innovations Engages Investment Bank to Pursue Nasdaq Cross-listing and Potential Concurrent Equity Offering
December 8, 2025
·
3 min read
Press Releases
ToolGen and GenEditBio Enter Strategic Cross-License Agreement to Accelerate Development of Innovative Genome-Editing Therapeutics
November 24, 2025
·
5 min read
Mergers & Acquisitions
Novo Strikes up to $5.2B Deal for Akero in Red-Hot MASH Space
Novo will add Akero’s efruxifermin to its MASH portfolio, which includes Wegovy after the GLP-1 gained an FDA nod in the indication earlier this year.
October 9, 2025
·
2 min read
·
Annalee Armstrong
Vaccines
Experts Say Axed ACIP Members’ Conflicts of Interest Are ‘a Red Herring’
In advance of this week’s CDC vaccine advisory meeting, HHS Secretary Robert F. Kennedy Jr. restacked the committee, claiming problematic industry ties within the previous group. Experts say ACIP had long navigated COIs appropriately and that the new appointees risk the apolitical nature of membership.
June 23, 2025
·
4 min read
·
Dan Samorodnitsky
Press Releases
Chiesi Group Enters into an Exclusive License Agreement with Aliada Therapeutics, a Wholly Owned Subsidiary of AbbVie, to Advance Blood-Brain Barrier-Crossing Platform Technology in Lysosomal Storage Disorders
November 13, 2025
·
3 min read
Lung cancer
Summit’s Keytruda Challenger Hits Cross-Country Consistency Problems, Raising US Approval Questions
Ivonescimab elicited better overall survival in Asian patients with non-small cell lung cancer than in those from North America and European countries, in Western countries narrowly missing the statistical significance threshold the FDA is seeking.
September 8, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Red Biotechnology Market Size to Reach USD 1,511.28 Billion by 2034
July 11, 2025
·
1 min read
Press Releases
Bausch + Lomb Announces Publication of Phase 3 Data on LUMIFY® Preservative Free Redness Reliever Eye Drops
July 30, 2025
·
4 min read
1 of 84,054
Next
